Abstract
Dengue fever is a mosquito-borne viral disease with strong seasonality, periodicity, and spatial heterogeneity, posing a persistent global public health threat. We present a hybrid modeling framework that couples a recurrent neural network (RNN) with a typical Susceptible–Infected–Recovered (SIR) compartmental model to investigate dengue transmission dynamics in Guangdong, China, from 2016 to 2024. By incorporating mosquito surveillance data, meteorological variables (temperature, humidity, and precipitation), public health intervention intensity, and reported dengue cases, our model captures the complex interactions among climate, vector density, intervention policies, and disease spread. After evaluating multiple RNN architectures, the Long Short-Term Memory (LSTM) model was selected for its superior performance in predicting the mosquito ovitrap index (MOI) from climatic variables, providing a data-driven proxy for vector abundance used in the SIR model. The hybrid model is constructed upon a partially observed Markov process (POMP) and calibrated using iterated filtering for parameter optimization. Model results identify climate variables as dominant drivers of dengue transmission, while non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic significantly suppressed case numbers. Scenario analysis indicates that moderate NPIs could effectively reduce outbreak magnitude, with the model estimating that approximately 46,120 dengue cases were averted during the pandemic period. This study highlights the utility of integrating deep learning with mechanistic modeling to improve understanding and forecasting of vector-borne disease dynamics. The proposed framework offers a robust and interpretable approach for developing climate- and vector-informed early warning systems and informing data-driven public health decision-making.
Author Summary Dengue fever is a mosquito-borne disease that causes large outbreaks in many tropical and subtropical regions, including southern China. Predicting when and where outbreaks will occur is difficult because dengue transmission is influenced by many factors, such as climate, mosquito populations, and public health measures. In this study, we developed a hybrid modeling framework that integrates artificial intelligence with mechanistic disease modeling. Specifically, we used a deep learning method to predict mosquito abundance from climate conditions and then linked to a mathematical model for dengue transmission. Applying this approach to data from Guangdong Province, China between 2016 and 2024, we found that climate strongly influences mosquito biting behavior, which in turn drives dengue transmission. We also showed that non-pharmaceutical interventions during the COVID-19 pandemic substantially reduced dengue cases, with our model estimating that more than 46,000 infections were prevented. Our innovative approach demonstrates how combining modern machine learning with mechanistic models can improve our ability to understand and forecast outbreaks of mosquito-borne diseases. Our framework may help inform early warning systems and guide public health strategies to reduce the burden of dengue and other vector-borne diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by the National Natural Science Foundation of China (Grant No. 12501689) and Guangdong Basic and Applied Basic Research Foundation (Grant No. 2025A1515011054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
